Seno Biotech Launches Egg Yolk Peptide, Phospholipid Protein and Egg Yolk Oil Series at HI & FI Asia-China 2026
Seno Biotech introduces traceable egg-derived bioactive ingredients for bone health, lipid nutrition, oral supplements and skincare formulations.

Yang Cui
Marketing Lead

From June 15 to 17, 2026, the 27th Health Ingredients & Food Ingredients Expo (Hi & Fi Asia-China 2026) was held at the National Exhibition and Convention Center (Shanghai). As a highly influential professional exhibition in Asia’s food ingredients sector, this year’s event brought together thousands of upstream and downstream enterprises from around the world, drawing a steady stream of visitors and fostering lively networking and discussion. Jilin Shengyang Biotechnology Co., Ltd. made a concentrated debut of three brand-new deep-processed egg-derived raw materials, officially launching its new product series. Leveraging the natural source of fresh eggs, stable processing characteristics, and multi-scenario adaptability, the booth attracted considerable attention from procurement professionals and R&D engineers in the health food, special dietary, and beauty & personal care sectors.
Backed by years of technical expertise in egg deep-processing, Jilin Shengyang Biotech showcased three core functional ingredients at the expo: hydrolyzed egg yolk powder, egg yolk phospholipid protein, and egg yolk oil, covering three major application tracks—dietary nutritional supplementation, oral lipid products, and skin care. The company provides compliant and diversified natural ingredient solutions for brand owners, addressing four key dimensions: production process, physicochemical specifications, application scenarios, and processing compatibility.
Hydrolyzed Egg Yolk Powder for Bone Health Nutrition
Hydrolyzed egg yolk powder is produced from fresh egg yolks through a multi-step process including enzymatic hydrolysis with proteases, heat treatment, centrifugation, and spray drying. The product exhibits excellent basic specifications: protein content ≥60%, and small-molecule peptides (molecular weight range 1,000–5,000 Da) accounting for ≥75% of total peptides, facilitating better absorption and utilization by the human body. The recommended daily intake is less than 1 g/day, making it suitable for formulation development in children’s nutritional supplements and daily bone health products for middle-aged and elderly consumers. At the expo, several composite nutritional formulation solutions drew strong interest from brands specializing in children’s foods and geriatric special dietary products.
Egg Yolk Phospholipid Protein for Brain Health and Lipid Nutrition
Egg yolk phospholipid protein is produced from egg yolk powder via CO₂ supercritical fluid low-temperature extraction, granulation, and multi-stage separation and purification, preserving the natural nutritional components of the raw material. The finished product maintains stable specifications: protein content ≥40% and phospholipid content ≥24%. The natural combination of protein and phospholipids offers synergistic nutritional benefits and can be widely used in daily nutritional foods, dietary supplements for middle-aged and elderly consumers, and functional foods targeting lipid health management.
Egg Yolk Oil for Oral Nutrition and Skincare Formulations
Egg yolk oil is also prepared using CO₂ supercritical fluid low-temperature extraction from egg yolk powder. The gentle processing preserves natural bioactive substances such as vitamins A, D, and E. The finished product displays a natural golden-yellow color and a mild, pleasant egg aroma without any pungent off-odor. In the cosmetic sector, it can be incorporated into skincare formulations for skin-nourishing purposes. The recommended addition ratio is 0.5%–1%, making it suitable for both food and cosmetic applications, thereby expanding the cross-category usage scenarios of egg-derived raw materials.
Market Demand for Natural Egg-Derived Bioactive Ingredients
Over the three exhibition days, Jilin Shengyang Biotech’s booth remained consistently busy, with visitors including domestic health food manufacturers, maternal and child nutrition brands, cosmetic companies, and overseas import/export buyers. The team provided one-on-one consultations on the production processes, physicochemical test data, processing tolerance, compliant formulation approaches, and bulk supply capabilities of the four new products, while also offering customized formulation reference solutions.
Visitors widely noted that today’s consumer market increasingly favors natural, single-source, and minimally chemically processed ingredients. As a well‑known natural food material, eggs offer substantial market potential for deep‑processed derivatives. Shengyang’s newly launched series, with their distinct differentiation and dual-track applicability in food and cosmetic sectors, secured multiple trial orders and in‑depth cooperation intentions on site.
A representative from Jilin Shengyang Biotech stated that the centralized launch of the new egg yolk product series at this Shanghai expo represents a key milestone in the company’s R&D achievements in egg‑based deep processing. The company remains committed to compliant production standards; all raw materials strictly adhere to national food and cosmetic regulatory requirements, with no added chemical auxiliaries, stable processes, and controllable specifications. Looking ahead, the company will continue to deepen R&D in functional egg‑derived natural ingredients, optimize existing products, and develop new categories, providing stable, highly adaptable natural raw materials for domestic and international food and cosmetic industry clients, and working alongside industry partners to unlock the broad market potential of natural egg‑based ingredients.
Note: The above products are ordinary food ingredients and are not intended to replace pharmaceuticals. They do not involve disease prevention, treatment, or therapeutic claims.


